ArticleThe Lancet. Haematology2016

Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.

Patrick B Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.